EP
JNJ icon

EPIQ Partners’s Johnson & Johnson JNJ Stock Holding History

EPIQ Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Sell
9,020
-240
-3% -$55.9K 0.97% 30
2026
Q1 		$2.26M Hold
9,260
– – 1.06% 28
2025
Q4 		$1.92M Hold
9,260
– – 0.89% 32
2025
Q3 		$1.72M Hold
9,260
– – 0.81% 35
2025
Q2 		$1.41M Hold
9,260
– – 0.72% 36
2025
Q1 		$1.54M Buy
9,260
+1
+0% +$156 0.81% 36
2024
Q4 		$1.34M Hold
9,259
– – 0.72% 35
2024
Q3 		$1.5M Sell
9,259
-11,865
-56% -$1.89M 0.83% 32
2024
Q2 		$3.09M Buy
21,124
+1,283
+6% +$191K 2.09% 22
2024
Q1 		$3.14M Sell
19,841
-448
-2% -$71.3K 2.09% 20
2023
Q4 		$3.18M Buy
20,289
+370
+2% +$56.7K 2.28% 17
2023
Q3 		$3.1M Buy
19,919
+6
+0% +$990 2.34% 14
2023
Q2 		$3.3M Buy
19,913
+330
+2% +$53.3K 2.24% 18
2023
Q1 		$3.04M Buy
19,583
+1,770
+10% +$286K 2.09% 19
2022
Q4 		$3.15M Sell
17,813
-952
-5% -$164K 2.09% 18
2022
Q3 		$3.06M Buy
18,765
+1,070
+6% +$181K 1.9% 20
2022
Q2 		$3.14M Buy
17,695
+2,776
+19% +$495K 1.92% 20
2022
Q1 		$2.64M Buy
14,919
+520
+4% +$88.5K 1.42% 28
2021
Q4 		$2.46M Buy
14,399
+369
+3% +$60.4K 1.31% 29
2021
Q3 		$2.27M Buy
14,030
+2,700
+24% +$461K 1.04% 39
2021
Q2 		$1.87M Buy
11,330
+232
+2% +$38.4K 0.94% 41
2021
Q1 		$1.82M Buy
11,098
+880
+9% +$142K 1.04% 37
2020
Q4 		$1.61M Buy
10,218
+1,197
+13% +$177K 1.12% 36
2020
Q3 		$1.3M Sell
9,021
-260
-3% -$38.5K 0.98% 38
2020
Q2 		$1.3M Hold
9,281
– – 1.19% 36
2020
Q1 		$1.22M Buy
9,281
+229
+3% +$32.5K 1.35% 32
2019
Q4 		$1.32M Buy
+9,052
New +$1.23M 1.34% 33

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

EPIQ Partners's JNJ Position: Q2 2026 in Review

EPIQ Partners reduced its Johnson & Johnson (JNJ) stake by 2.6% in Q2 2026, selling an estimated $55.9K and leaving 9,020 shares worth $2.29M. The position accounts for 0.97% of the portfolio, ranked #30.

EPIQ Partners first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.3M in Q2 2023. 1,131 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • EPIQ Partners held 9,020 shares of Johnson & Johnson worth $2.29M as of Q2 2026.
  • EPIQ Partners sold 240 Johnson & Johnson shares in Q2 2026, an estimated $55.9K.
  • Johnson & Johnson made up 0.97% of EPIQ Partners's portfolio in Q2 2026, its #30 holding.
  • EPIQ Partners first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • EPIQ Partners's Johnson & Johnson position peaked at $3.3M in Q2 2023.
  • 1,131 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on EPIQ Partners's 13F filing for Q2 2026, filed 7 Jul 2026.